Top Markets
Coin of the day
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd

HLB Pharmaceutical Co., Ltd

047920
Rang in Aktien #19339
HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to... HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to the research and development of peptide-based drugs. Its product line encompasses a wide array of pharmaceutical preparations. These include medications for skeletal muscle relaxation, tranquilizing effects, antihistamine action, hypertension management, pain alleviation, anti-itching, astringent properties, anti-inflammatory relief, alimentary system support, metabolic regulation, ophthalmic conditions, local anesthesia, anti-arteriosclerosis, expectoration, fever reduction, analgesia, diabetes control, chemotherapy, peptic ulcer treatment, central nervous system issues, bacterial infections (antibiotics), digestive assistance, antacid needs, dental care, multivitamin supplementation, parasitic skin diseases, dermatological concerns, urogenital organ function, amino acid replacement, cough suppression, mucus thinning, parasitic worm elimination, diarrhea relief, circulatory system disorders, vitamin deficiencies, skin softening, hemorrhoid treatment, and liver ailments. Additionally, the company is actively developing CTT-004, an investigational therapy for ataxia associated with spinocerebellar degeneration, and offers Contract Manufacturing Organization (CMO) services. The enterprise, established in 1998, was formerly recognized as Mediforum Pharmaceutical Incorporation before adopting the name HLB Pharmaceutical Co., Ltd in October 2020. Its headquarters are located in Namyangju-Si, South Korea.
Aktienkurs
$5.04
Marktkapitalisierung
$165.34M
Veränderung (1 Tag)
-4.46%
Veränderung (1 Jahr)
-48.26%
Land
KR
Handel HLB Pharmaceutical Co., Ltd (047920)

Kategorie

Preis 047920 mit Marktkapitalisierung von B
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
047920
$5.04
Marktkapitalisierung von HLB Pharmaceutical Co., Ltd(047920)
Marktkapitalisierung: $165.34M
Mit Stand August 2026 hat HLB Pharmaceutical Co., Ltd eine Marktkapitalisierung von $165.34M. Das macht HLB Pharmaceutical Co., Ltd laut unseren Daten zum 19339th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von HLB Pharmaceutical Co., Ltd von 2015 bis 2026
047920 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 047920 Vermögenswert B Marktkapitalisierung von B Ergebnisse
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$157,094 $165.34M
$5.152T +3,116,225.47%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$138,329 $165.34M
$4.537T +2,743,979.31%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$127,095 $165.34M
$4.169T +2,521,131.61%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$111,051 $165.34M
$3.642T +2,202,865.08%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$85,512.30 $165.34M
$2.805T +1,696,240.01%